These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12905563)

  • 1. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma (Br J Surg 2003; 90: 325-331).
    Sen G; Rai R; Manas DM
    Br J Surg; 2003 Aug; 90(8):1022. PubMed ID: 12905563
    [No Abstract]   [Full Text] [Related]  

  • 2. Without victory there is no survival: transarterial lipiodol chemoembolization and hepatocellular carcinoma.
    Sudan D; Sudan R; Schafer D; Langnas A
    Hepatology; 1998 Jul; 28(1):270-1. PubMed ID: 9657124
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome.
    Huo TI; Wu JC; Huang YH; Chiang JH; Lee PC; Chang FY; Lee SD
    Aliment Pharmacol Ther; 2004 May; 19(9):999-1007. PubMed ID: 15113367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
    Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
    Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival after transarterial chemoembolization for hepatocellular carcinoma.
    Iozzino M; Spaziani E; Picchio M; Saltarelli A; Di Filippo A; De Angelis F; Narilli F; Stagnitti F; Cianni R
    Clin Ter; 2011; 162(2):129-32. PubMed ID: 21533319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncharacteristically early fatal intraperitoneal rupture of hepatocellular carcinoma following transarterial chemoembolization.
    Reichman TW; Anthony T; Millis JM; Testa G
    Dig Liver Dis; 2009 Feb; 41(2):175-6. PubMed ID: 18849205
    [No Abstract]   [Full Text] [Related]  

  • 7. Preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.
    Kobayashi T; Teruya M
    Ann Surg; 2010 Feb; 251(2):386; author reply 386-7. PubMed ID: 20040849
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypothyroidism in patients with hepatocellular carcinoma treated by transarterial chemoembolization.
    Flohr F; Harder J; Seufert J; Blum HE; Spangenberg HC
    Hepatology; 2008 Jun; 47(6):2144. PubMed ID: 18459123
    [No Abstract]   [Full Text] [Related]  

  • 9. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
    Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
    J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoembolization and bland embolization: a critical appraisal.
    Befeler AS
    Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.
    Brown DB; Fundakowski CE; Lisker-Melman M; Crippin JS; Pilgram TK; Chapman W; Darcy MD
    J Vasc Interv Radiol; 2004 Nov; 15(11):1209-18. PubMed ID: 15525739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study.
    Dharancy S; Boitard J; Decaens T; Sergent G; Boleslawski E; Duvoux C; Vanlemmens C; Meyer C; Gugenheim J; Durand F; Boillot O; Declerck N; Louvet A; Canva V; Romano O; Ernst O; Mathurin P; Pruvot FR
    Liver Transpl; 2007 May; 13(5):665-71. PubMed ID: 17427172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter.
    Huang YH; Wu JC; Chen SC; Chen CH; Chiang JH; Huo TI; Lee PC; Chang FY; Lee SD
    Aliment Pharmacol Ther; 2006 Jan; 23(1):129-35. PubMed ID: 16393290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    Cho YK; Chung JW; Kim JK; Ahn YS; Kim MY; Park YO; Kim WT; Byun JH
    Cancer; 2008 Jan; 112(2):352-61. PubMed ID: 18008352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for distant recurrence of HCV-related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization.
    Fuke H; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Yoneda K; Yamamoto N; Ito K; Takaki H; Nakatsuka A; Yamakado K; Takeda K; Takei Y
    Aliment Pharmacol Ther; 2008 Jun; 27(12):1253-60. PubMed ID: 18221404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoembolization for hepatocellular carcinoma.
    Zangan SM; Patel J
    Semin Roentgenol; 2011 Apr; 46(2):105-14. PubMed ID: 21338835
    [No Abstract]   [Full Text] [Related]  

  • 18. Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma.
    Otto G; Heise M; Moench C; Herber S; Bittinger F; Schuchmann M; Hoppe-Lotichius M; Pitton M
    Transplant Proc; 2007 Mar; 39(2):537-9. PubMed ID: 17362776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial chemoembolization for hepatocellular carcinoma.
    Lau WY; Yu SC; Lai EC; Leung TW
    J Am Coll Surg; 2006 Jan; 202(1):155-68. PubMed ID: 16377509
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of a safety index of transarterial chemoembolization for hepatocellular carcinoma to prevent acute liver damage.
    Hwang JI; Chow WK; Hung SW; Li TC; Cheng YP; Ho YJ; Lin CC
    Anticancer Res; 2005; 25(3c):2551-4. PubMed ID: 16080491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.